GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 53,000 full-time employees. The company went IPO on 2022-12-15. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
Follow-Up Questions
What is GE Healthcare Technologies Inc (GEHC)'s P/E Ratio?
The P/E ratio of GE Healthcare Technologies Inc is 16.5718
Who is the CEO of GE Healthcare Technologies Inc?
Mr. Peter Arduini is the President of GE Healthcare Technologies Inc, joining the firm since 2022.
What is the price performance of GEHC stock?
The current price of GEHC is $73.66, it has decreased 1.71% in the last trading day.
What are the primary business themes or industries for GE Healthcare Technologies Inc?
GE Healthcare Technologies Inc belongs to Health Care industry and the sector is Health Care
What is GE Healthcare Technologies Inc market cap?
GE Healthcare Technologies Inc's current market cap is $33.6B
Is GE Healthcare Technologies Inc a buy, sell, or hold?
According to wall street analysts, 23 analysts have made analyst ratings for GE Healthcare Technologies Inc, including 9 strong buy, 11 buy, 7 hold, 0 sell, and 9 strong sell
